Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension

Recruiting Phase 1 Interventional Study
Healthy Volunteers Essential Hypertension
Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
160 (estimated)
Sponsor
Kyowa Kirin Co., Ltd. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Part 1 : To evaluate the safety of single-dose KK3910 in healthy volunteers. Part 2 : To evaluate the safety of multiple-dose KK3910 in patients with essential hypertension. Part 3 : To assess the safety profile of repeated dosing of KK3910 in an additional hypertension cohort.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Part 1 * Voluntary consent to participate in this study must be given (in writing) * Japanese healthy adults or non-Asian healthy men 18 to \< 55 years at the time of informed consent ( Japanese healthy adults 65 to \< 80 years for the elderly cohort) * BMI is within the specifi…
Contacts

Kyowa Kirin Co., Ltd.

+81-3-5205-7200

clinical.info.jp@kyowakirin.com

CONTACT